Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Rovsing (Investment Case): Looking beyond space, delivering on the pipeline first

ROVResearch16.11.2026 klo 16.45
Michael Friis, Victor Skriver
Download report (PDF)

Summary

  • Q1 revenue fell to DKK 2.6m from DKK 7.3m, and EBITDA to DKK -2.7m from DKK -0.6m. Rovsing maintained guidance of DKK 27–34m revenue and DKK -4m to 0m EBITDA, weighted to the second half.
  • ESA and Denmark anchor the growth plan. Management expects orders to start in 2026/27 and the full revenue impact in 2027/28, with the roughly DKK 150m pipeline marking the first visible output of the larger funding cycle.
  • The analyst sees near-term performance hinging on tender timing and pipeline conversion. Project-hour overruns, a DKK 21.6m backlog and backend-loaded guidance raise execution risks.
  • Rovsing trades at 1.5x EV/Sales on 2027E versus a peer median of 1.7x. The analyst says the near-term investment case rests on order intake rather than quarterly results.

This content is generated by AI. You can give feedback on it in the Inderes forum.

In connection with Rovsing’s interim management statement for Q1 2026/27 and the strategy update presented on 10 November, we have updated our investment case, which covers investment reasons and risks as well as valuation perspectives.

Q1 was weak, and in itself not the most interesting part of the quarter. Revenue was DKK 2.6m against DKK 7.3m last year and EBITDA was DKK -2.7m against DKK -0.6m, driven by higher than planned consumption of project hours, delays in ongoing projects, and prime contractors postponing decisions on tenders. Order intake was DKK 5.9m and the backlog ended at DKK 21.6m. Guidance for the year is maintained at revenue of DKK 27 to 34m and EBITDA of DKK -4m to 0m, with the contribution weighted towards the second half.

The more important event was the strategy update from new CEO Lars Gregersen, which puts a structure on how the case is supposed to work.

Growth rests on three drivers. The first is ESA and Denmark, which carries the targets. The second is commercial and adjacent markets, which is upside and not included in the plan. The third is buy & build, which is at screening stage with no transaction agreed and would require separate financing.

Driver one is a question of timing rather than of funding. CM25 committed a record EUR 22.3bn for 2026 to 2028, around 32% above the previous period, and Denmark raised its total commitment to DKK 2.7bn, with voluntary programmes rising from roughly DKK 700 to 800m to around DKK 1.1bn. ESA is obliged to return at least 95% of voluntary contributions to the member state as industrial contracts, which channels a far larger budget towards a small Danish supplier base. The money is committed. What stands between the budget and Rovsing’s P&L is a lag of 12 to 24 months, because ESA first negotiates with the primes and Rovsing cannot bid until a prime has settled what is to be tested. FY 2025/26 therefore ran on contracts from the previous cycle, and the pipeline of around DKK 150m is the first visible output of the new one. Management expects orders to start flowing in 2026/27 and the full revenue effect in 2027/28, followed by illustrative annual growth of around 10%.

What makes that matter for earnings is the cost base. Capacity is in place and largely fixed, and management estimates that about a third of additional revenue reaches EBITDA, which is why the distance from the guidance range to a positive result is small enough that a single contract win can close it. The product roadmap works in the same direction. SLP200A was co-developed under ESA ARTES with a first batch going to a US prime, and a further four to five products are ready to be produced and shelved. Standardised products are developed once and sold repeatedly, which shortens delivery times and reduces the bespoke development carried per order, and they can be sold to customers and competitors where Rovsing is not the system supplier.

Driver two carries the longer term case, but it is also where investors are likely to want proof before paying for it. Commercial space accounts for around 20% of the market and is funded independently of public budgets, while defence, traction and automotive share the same need for expensive test equipment and strict specifications. New geographies are approached through local agents rather than through own sales capacity, and the Marble Imaging partnership opens the downstream data market from 2027. The strategic argument is not only incremental revenue, but a revenue base that is less dependent on a single agency budget cycle. For now these are first indications, and defence in particular is slow, as equipment is renewed rarely and then produced for decades. 

The risks are near term and mostly about timing. Guidance is heavily backend loaded after a weak Q1, and the order book of DKK 21.6m covers only part of what the range requires. Project hours have overrun in two consecutive reporting periods. New ESA contracts carry prepayments, which means delayed awards affect liquidity as well as revenue, and buy & build would require separate financing that could dilute shareholders.

On valuation, Rovsing trades at 1.5x EV/Sales on 2026, which reflects the realised figures, against a peer median of 2.6x, and at 1.5x on 2027E, derived from the 2026/27 guidance, against 1.7x. The gap to peers has narrowed since our last update as peer multiples have fallen. Part of the discount reflects growth, with Rovsing’s guidance midpoint implying around -1% against a peer median of 36% in 2027E, and the rest reflects a backlog near the bottom of the cycle.

EV/EBITDA is not meaningful at the current earnings level. In 2023/24, revenue of DKK 39.3m delivered EBITDA of DKK 2.9m and a margin of 7.5%, with the order book at its DKK 65m peak. On today’s EV of around DKK 45m, even that level of earnings is not cheap, so the case is not a return to the previous peak but whether a cycle with a 32% larger budget can take the business beyond it.

In the near term the case remains a question of order intake rather than of the quarterly result, with the first tender decisions falling during 2026/27. The strategy looks beyond space, but the next twelve months are about converting what is already in the pipeline.

You can hear more about the quarter and the strategy update in the event we hosted with CEO Lars Gregersen: https://www.inderes.dk/en/videos/rovsing-praesentation-af-interim-management-statement-for-q1-202627

Disclaimer: HC Andersen Capital receives payment from Rovsing for a Digital IR subscription agreement. /Michael Friis and Victor Skriver, 15:45, 16/11-2026

Login required

This content is only available for logged in users

Create account

Rovsing is a technology company. The company specializes in technical development of systems, products and software solutions for the satellite and space industry. Examples of solutions that the company develops are check-out and validation systems. In addition, related engineering services are offered. Rovsing was founded in 1992 and is headquartered in Glostrup.

Read more on company page